SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq:RXDX), a biotechnology company focused
on precision medicine in oncology, announced today that Jonathan Lim,
M.D., its Chairman and Chief Executive Officer, will make a presentation
at the Ladenburg Thalmann 2017 Healthcare Conference on Tuesday,
September 26, 2017, at 2:00 p.m. Eastern time (11:00 a.m. Pacific time)
in New York, NY.
A webcast of the presentation will be available during the presentation
in the Investors section of the company’s website at https://www.ignyta.com/investors/,
and will be archived and available at that site for 14 days.
About Ignyta, Inc.
At Ignyta, we work tirelessly on behalf of patients with cancer to offer
potentially life-saving, precisely targeted therapeutics (Rx) guided by
diagnostic (Dx) tests. Our integrated Rx/Dx strategy allows us to enter
uncharted territory, illuminating the molecular drivers of cancer and
quickly advancing treatments to address them. This approach embraces
even those patients with rare cancers, who have the highest unmet need
and who may otherwise not have access to effective treatment options.
With our pipeline of potentially first-in-class or best-in-class
precision medicines, we are pursuing the ultimate goal of not just
shrinking tumors, but eradicating cancer relapse and recurrence in
precisely defined patient populations.
For more information, please visit: www.ignyta.com.
Image may be NSFW.
Clik here to view.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170918005331/en/
Source: Ignyta, Inc.
Cet article Ignyta to Present at the Ladenburg Thalmann 2017 Healthcare Conference est apparu en premier sur EEI-BIOTECHFINANCES.
